<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Ethanolamine oleate: Drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Ethanolamine oleate: Drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Ethanolamine oleate: Drug information</div><div class="clear"></div><div id="topicText">(For additional information <a class="drug drug_patient" data-topicid="116619" href="/d/html/116619.html" rel="external">see "Ethanolamine oleate: Patient drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F168117"><span class="drugH1">Brand Names: US</span>
<ul>
<li>Ethamolin</li></ul></div>
<div class="ex_sect_xr thclist drugH1Div drugBrandNames" id="F168124"><span class="drugH1">Pharmacologic Category</span>
<ul>
<li>
                        Sclerosing Agent</li></ul></div>
<div class="block doa drugH1Div" id="F168118"><span class="drugH1">Dosing: Adult</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="303fe938-a354-472c-bb64-d50de5be09b8">Esophageal varices</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Esophageal varices:</b>
<b>IV:</b> 1.5 to 5 mL per varix (maximum: 20 mL per treatment session). Treatments may be made at the time of the acute bleed and then repeated after 1 week, 6 weeks, 3 months, and 6 months as indicated. <b>Note:</b> Patients with cardiopulmonary disease should usually receive less than the maximum recommended dose.</p></div>
</div>
</div>
<div class="block dora drugH1Div" id="F50990224"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling. </p></div>
<div class="block doha drugH1Div" id="F50987530"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling;  patients with Child-Pugh class C hepatic impairment should usually receive less than the recommended maximum dosage.</p></div>
<div class="block doe drugH1Div" id="F168119"><span class="drugH1">Dosing: Older Adult</span>
<p style="text-indent:0em;display:inline">Refer to adult dosing.</p></div>
<div class="block adr drugH1Div" id="F168106"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified.</p>
<p style="text-indent:-2em;margin-left:2em;">1% to 10%:</p>
<p style="text-indent:-2em;margin-left:4em;">Cardiovascular: Substernal pain (2%)</p>
<p style="text-indent:-2em;margin-left:4em;">Gastrointestinal: Esophageal stenosis (1%), esophageal ulcer (2%)</p>
<p style="text-indent:-2em;margin-left:4em;">Respiratory: Pleural effusion (≤2%, including infiltration), pneumonia (1%)</p>
<p style="text-indent:-2em;margin-left:4em;">Miscellaneous: Fever (2%)</p>
<p style="text-indent:-2em;margin-left:2em;">&lt;1%: Gastrointestinal: Disease of esophagus (including esophageal perforation, esophagitis, local tissue necrosis, periesophageal abscess, and tissue sloughing)</p>
<p style="text-indent:-2em;margin-left:2em;">Postmarketing:</p>
<p style="text-indent:-2em;margin-left:4em;">Gastrointestinal: Biliary tract disease (biliary stricture) (Luman 1994)</p>
<p style="text-indent:-2em;margin-left:4em;">Hematologic &amp; oncologic: Disseminated intravascular coagulation, hematoma (esophageal) (Bak 1988)</p>
<p style="text-indent:-2em;margin-left:4em;">Hypersensitivity: Anaphylaxis</p>
<p style="text-indent:-2em;margin-left:4em;">Renal: Acute kidney injury</p>
<p style="text-indent:-2em;margin-left:4em;">Respiratory: Pulmonary edema (Lee 1994)</p></div>
<div class="block coi drugH1Div" id="F168115"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;display:inline">Hypersensitivity to ethanolamine, oleic acid, ethanolamine oleate, or any component of the formulation.</p></div>
<div class="block war drugH1Div" id="F168103"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Concerns related to adverse effects:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Anaphylaxis: Fatal anaphylactic shock following an injection of a larger than normal volume has been reported following administration.</p>
<p style="text-indent:-2em;margin-left:4em;">• Injection necrosis: Severe injection necrosis may result from direct injection of sclerosing agents, especially if excessive volumes are used; fatal case of extensive esophageal necrosis and death has been reported.</p>
<p style="text-indent:-2em;margin-left:4em;">• Renal effects: Acute renal failure with spontaneous recovery has been reported.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Disease-related concerns:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Cardiorespiratory disease: Use with caution in patients with concomitant cardiorespiratory disease; minimize total dose per treatment session and monitor carefully.</p>
<p style="text-indent:-2em;margin-left:4em;">• Hepatic impairment: Use with caution in patients with Child-Pugh class C hepatic impairment, as they are more likely to develop esophageal ulceration; less than the maximum dose is recommended.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Special populations:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Critically ill patients: Use with caution in critically ill patients due to increased risk of aspiration pneumonia.</p>
<p style="text-indent:-2em;margin-left:4em;">• Older adult: Use with caution in the elderly due to increased risk of aspiration pneumonia (has been fatal).</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Other warnings/precautions: </i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Appropriate use: Not indicated for the treatment of esophageal varices that have not bled or for varicosities of the leg; submucosal injection is not recommended due to ulceration, necrosis, and delayed esophageal perforation complications.</p></div>
<div class="block foc drugH1Div" id="F168111"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, Intravenous: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Ethamolin: 5% (2 mL) [contains benzyl alcohol]</p></div>
<div class="block geq drugH1Div" id="F168099"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">No</p></div>
<div class="block fee drugH1Div" id="F16323136"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Ethamolin Intravenous)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">5% (per mL): $288.24</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block adm drugH1Div" id="F168113"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:0em;display:inline">Use acceptable injection technique to avoid necrosis (may result from direct injection of sclerosing agents), especially if excessive volumes are use. Avoid submucosal injections (risk of ulceration and necrosis).  </p></div>
<div class="block use drugH1Div" id="F168112"><span class="drugH1">Use: Labeled Indications</span>
<p style="text-indent:0em;display:inline">
<b>Esophageal varices:</b> Treatment of esophageal varices that have recently bled, to prevent rebleeding.  </p></div>
<div class="block mst drugH1Div" id="F168130"><span class="drugH1">Medication Safety Issues</span>
<div class="collapsible">
<span class="collapsible-title">Sound-alike/look-alike issues: </span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:4em;">Ethamolin may be confused with ethanol</p></div>
</div>
</div>
<div class="block cyt drugH1Div" id="F13299291"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F168108"><span class="drugH1">Drug Interactions</span>
<br/><br/><div class="clear"></div><p style="text-indent:0em;display:inline">There are no known significant interactions.</p></div>
<div class="block pri drugH1Div" id="F13801059"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;display:inline">Animal reproduction studies have not been conducted.</p></div>
<div class="block brc drugH1Div" id="F20617115"><span class="drugH1">Breastfeeding Considerations</span>
<p style="text-indent:0em;display:inline">It is not known if ethanolamine oleate is excreted in breast milk. The manufacturer recommends that caution be exercised when administering ethanolamine oleate to nursing women.</p></div>
<div class="block pha drugH1Div" id="F168102"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">Ethanolamine oleate produces a sterile dose-related inflammatory response resulting in fibrosis and possible occlusion of the vein; a dose-related extravascular inflammatory reaction occurs when the drug diffuses through the venous wall. </p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F58190732"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(AU)</span> <span class="country">Australia</span><span class="countrySeparator">: </span><span class="drugName">Ethamolin</span>;</li>
<li>
<span class="countryCode">(BR)</span> <span class="country">Brazil</span><span class="countrySeparator">: </span><span class="drugName">Ethamolin</span>;</li>
<li>
<span class="countryCode">(CO)</span> <span class="country">Colombia</span><span class="countrySeparator">: </span><span class="drugName">Antivar</span>;</li>
<li>
<span class="countryCode">(EC)</span> <span class="country">Ecuador</span><span class="countrySeparator">: </span><span class="drugName">Ethamolin</span>;</li>
<li>
<span class="countryCode">(GB)</span> <span class="country">United Kingdom</span><span class="countrySeparator">: </span><span class="drugName">Ethanolam olea | Ethanolamine</span>;</li>
<li>
<span class="countryCode">(JO)</span> <span class="country">Jordan</span><span class="countrySeparator">: </span><span class="drugName">Ethanolamine Oleat</span>;</li>
<li>
<span class="countryCode">(JP)</span> <span class="country">Japan</span><span class="countrySeparator">: </span><span class="drugName">Oldamin</span>;</li>
<li>
<span class="countryCode">(KR)</span> <span class="country">Korea, Republic of</span><span class="countrySeparator">: </span><span class="drugName">Ethanolamine | Ethanolamine Far</span>;</li>
<li>
<span class="countryCode">(PR)</span> <span class="country">Puerto Rico</span><span class="countrySeparator">: </span><span class="drugName">Ethamolin</span>;</li>
<li>
<span class="countryCode">(VE)</span> <span class="country">Venezuela, Bolivarian Republic of</span><span class="countrySeparator">: </span><span class="drugName">Ethamolin</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference" id="lexi-content-ref-3153802">
<a name="3153802"></a>Bak YT, Yu ZM, Cho JY, Kim JH, Kim JG, Lee CH. Intramural hematoma of the esophagus: unusual complication of esophageal variceal sclerotherapy. <i>Korean J Intern Med</i>. 1988;3(1):92-94. doi:10.3904/kjim.1988.3.1.92<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/ethanolamine-oleate-drug-information/abstract-text/3153802/pubmed" id="3153802" target="_blank">3153802</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Ethamolin (ethanolamine) [prescribing information]. Vero Beach, FL: QOL Medical; August 2012.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-7865488">
<a name="7865488"></a>Lee JY, Moon SH, Lee SM, et al. A case of noncardiogenic pulmonary edema by ethanolamine oleate. <i>Korean J Intern Med</i>. 1994;9(2):125-127. doi:10.3904/kjim.1994.9.2.125<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/ethanolamine-oleate-drug-information/abstract-text/7865488/pubmed" id="7865488" target="_blank">7865488</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-7828994">
<a name="7828994"></a>Luman W, Hudson N, Choudari CP, Eastwood MA, Palmer KR. Distal biliary stricture as a complication of sclerosant injection for bleeding duodenal ulcer. <i>Gut</i>. 1994;35(11):1665-1667. doi:10.1136/gut.35.11.1665<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/ethanolamine-oleate-drug-information/abstract-text/7828994/pubmed" id="7828994" target="_blank">7828994</a>]</span>
</div>
</li></ol></div><div id="topicVersionRevision">Topic 9431 Version 98.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
